|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Chronic Heart Failure | |||||
| Heart Diseases | |||||
| Anemia, Iron-Deficiency | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Heart Failure | |||||
| 3 | More general conditions related to this trial | ||||
| Anemia | |||||
| Anemia, Hypochromic | |||||
| Cardiovascular Diseases | |||||
| Hematologic Diseases | |||||
| Iron Metabolism Disorders | |||||
| Metabolic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Venofer (intravenous iron sucrose) | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Ferric oxide, saccharated | |||||
| 6 | More general drug interventions related to this trial | ||||
| Hematinics | |||||
| Hematologic Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| National Heart and Lung Institute | |||||
| Wexham Park Hospital | |||||
| 4th Military Hospital, Poland | |||||